Ecopetrol
EC
Coinbase
COIN
MicroStrategy
MSTR
Petroleo Brasileiro SA Petrobras
PBR
MARA Holdings
MARA
US Stock MarketDetailed Quotes
OCGN Ocugen
- 0.9000
- +0.0950+11.80%
Close Jan 2 16:00 ET
- 0.9154
- +0.0154+1.71%
Post 19:59 ET
262.19MMarket Cap-4.74P/E (TTM)
0.9687High0.8451Low9.74MVolume0.8650Open0.8050Pre Close8.96MTurnover3.39%Turnover RatioLossP/E (Static)291.32MShares2.105052wk High6.47P/B258.60MFloat Cap0.490552wk Low--Dividend TTM287.33MShs Float778.1999Historical High--Div YieldTTM15.35%Amplitude0.1700Historical Low0.9190Avg Price1Lot Size
About Ocugen Company
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Company Profile
SymbolOCGN
Company NameOcugen
Listing DateDec 3, 2014
Issue Price11.00
Founded2013
CEODr. Shankar Musunuri, M.B.A.,PhD
MarketNASDAQ
Employees65
Fiscal Year Ends12-31
Address11 Great Valley Parkway
CityMalvern
ProvincePennsylvania
CountryUnited States of America
Zip Code19355
Phone1-484-328-4701
Websitehttp://www.ocugen.com
Company Executives
- Name
- Position
- Salary
- Dr. Shankar Musunuri, M.B.A.,PhD
- Chairman of the Board and Chief Executive Officer
- --
- Arun Upadhyay, PhD
- Chief Scientific Officer and Head, Research, Development, and Medical
- --
- Ramesh Ramachandran
- Principal Financial Officer and Chief Accounting Officer
- --
- Dr. Huma Qamar, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Prabhavathi Fernandes, PhD
- Lead Independent Director
- --
- Uday B. Kompella, PhD
- Independent Director
- --
- Kirsten Castillo, M.B.A.
- Independent Director
- --
- Dr. Marna C. Whittington, PhD
- Independent Director
- --
- Dr. Junge Zhang, PhD
- Independent Director
- --
- Michael Breininger, C.P.A.,M.B.A.
- Corporate Controller
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.